Stocks · Health care · Biological Products, (No Diagnostic Substances)

Metagenomi Therapeutics, Inc.

MGX Clue Score24
United States Fiscal year ends December CIK 0001785279 Results filed 10 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Laurence Reid
9 Sep 2026
Director
Buy
117
$1.18
$138.06
Laurence Reid
9 Sep 2026
Director
Buy
19,883
$1.17
$23.26K
Novo Holdings A/S
13 Feb 2024
10% owner
Buy
800,000
$15.00
$12.00M
Novo Holdings A/S
9 Feb 2024
10% owner
Buy
100,000
$10.25
$1.03M

What was left out

Form 4 filings counted 58
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 8,578,746
History held since 14 Feb 2024